Profil
Vincent W.
Coljee was the founder of Excelimmune, Inc. which was founded in 2006, where he held the title of Chief Scientific Officer from 2010 to 2013.
Currently, he holds the title of Principal at Harvard University.
In the past, he held the title of Principal at Symphogen A.
Postes actifs de Vincent W. Coljee
| Sociétés | Poste | Début |
|---|---|---|
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Vincent W. Coljee
| Sociétés | Poste | Fin |
|---|---|---|
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Corporate Officer/Principal | - |
Excelimmune, Inc.
Excelimmune, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory and biotechnology services | Fondateur | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 3 |
|---|---|
Excelimmune, Inc.
Excelimmune, Inc. Miscellaneous Commercial ServicesCommercial Services Provides laboratory and biotechnology services | Commercial Services |
Harvard University
Harvard University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Symphogen A/S
Symphogen A/S BiotechnologyHealth Technology Develops antibody therapeutics for the treatment of cancers | Health Technology |
















